Stroke Prevention in Atrial Fibrillation
VideosWebinarsKey ArticlesIndependent Medical EducationNew This MonthGuidelinesRandomised Controlled TrialsMeta-AnalysesReal World studiesDabigatranRivaroxabanEdoxabanApixabanDiabetesElderlyHypertensionValvular Heart DiseaseOther studiesReviewsSpecific Clinical IndicationsPractical Aspects of UseReversal AgentsStrategies
Literature review: stroke prevention in atrial fibrillation
The review includes the pivotal randomised controlled trials for warfarin and direct oral anticoagulants as well as relevant publications from the last 18 months. The following search terms were used: ‘stroke prevention’, ‘atrial fibrillation’, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, ‘oral anticoagulants’, ‘non-VKA oral anticoagulants’, novel oral anticoagulants’, ‘direct oral anticoagulants’, ‘reversal agents’
New This Month
-
Orly Vardeny, Muthiah VaduganathanJACC Heart Fail. 2019;7:169-172
-
Deborah M. Siegal, Stuart J. ConnollyCirculation. 5 February, 2019;139:757-759.
-
Andrea RubboliEur J Intern Med. 19 January, 2019. pii: S0953-6205(19)30017-2. Epub ahead of print.
-
Giuseppe Patti, Ladislav Pecen, Markus Lucerna, et alAm J Med. 18 January, 2019. pii: S0002-9343(19)30071-3. Epub ahead of print.
Videos
-
08 February 2019 -
08 February 2019 -
06 February 2019 -
06 February 2019 -
14 November 2018 -
14 November 2018
Pages
Webinars
-
Dr Robert Byrne, Prof Georg Nickenig, Prof Stefan Hohnloser, Prof Georg Nickenig, Prof Pepe Zamorano, Dr Jose Lopez-Sendon. -
Gheorghe-Andrei Dan -
Dr. Amit Mistri
Key Articles
-
Jason G Andrade, Nathaniel M. Hawkins, Christopher B. Fordyce, et alAndrade JG al. Can J Cardiol. 2018. Article in press.
-
Deirdre A Lane, Juliane Meyerhoff, Ute Rohner, et alLane DA et al. Clin Cardiol. 2018;41:855-861. 12 June, 2018. Epub ahead of print.
-
Christina Ji-Young Lee, Thomas Alexander Gerds, Nicholas Carlson, et alLee CJ et al. J Am Coll Cardiol. 2018;72:17-26.
-
Stefan H Hohnloser, John W. EikelboomHohnloser SH and Eikelboom JW. J Am Coll Cardiol. 2018;72:27-28.
Independent Medical Education
-
Byrne R, Hohnloser S, Nickenig G, Sendon JL and Zamarano JL, Radcliffe-CME, Feb 2018. -
Harald Darius -
Hugh Calkins, A John Camm
-
Richard Hobbs
Guidelines/ Expert Recommendations
-
Gheorghe-Andrei Dan, Konstantinos Iliodromitis, Daniel Scherr, et alDan GA et al. Europace. 8 June, 2018. Epub ahead of print.
-
J. Steffel, Peter Verhamme, Tatjana S Potpara, et alSteffel J et al. Eur Heart J. 17 March, 2018. Epub ahead of print.
Randomised Controlled Trials
-
Stefan H Hohnloser, John W. EikelboomHohnloser SH and Eikelboom JW. J Am Coll Cardiol. 2018;72:27-28.
-
Emily C. O'Brien, DaJuanicia N. Holmes, Laine Thomas, et alO’Brien EC et al. J Am Heart Assoc. 2018;7:pii: e006391.
-
Luigi Di Biase, Jorge RomeroDi Biase L and Romero J. JACC Clin Electrophysiol. 2018;4:601-603.
Post-Hoc/Subgroup Analysis Of Pivotal Trials - Dabigatran
-
Stefan H Hohnloser, John W. EikelboomHohnloser SH and Eikelboom JW. J Am Coll Cardiol. 2018;72:27-28.
-
Sara Själander, Vilhelm Sjögren, Henrik Renlund, et alSjälander S et al. Thromb Res. 2018;167:113-118.
-
Stephan Glund, Guanfa Gan, Viktoria Moschetti, et alGlund S et al. Clin Appl Thromb Hemost. 1 January, 2018: 1076029618755947. Epub ahead of print.
Post-Hoc/Subgroup Analysis Of Pivotal Trials - Rivaroxaban
-
Sara Själander, Vilhelm Sjögren, Henrik Renlund, et alSjälander S et al. Thromb Res. 2018;167:113-118.
-
The Medical Letter, Inc. Med Lett Drugs Ther. 2018;60:99-101.
Post-Hoc/Subgroup Analysis Of Pivotal Trials - Apixaban
-
The Medical Letter, Inc. Med Lett Drugs Ther. 2018;60:99-101.
Post-Hoc/Subgroup Analysis Of Pivotal Trials - Diabetes
-
David A. McAllister, Stephanie Read, Jan Kerssens, et alCIRCULATIONAHA.118.034986. Epub ahead of print.
-
Michael E. Nassif, Mikhail KosiborodNassif ME and Kosiborod M. Circulation. 2018;138:4-6.
-
Shilpa Vijayakumar, Muthiah Vaduganathan, Javed Butler, et alVijaykumar S et al. Circulation. 2018;137:1060-1073.
-
Petar M Seferovic, Mark C. Petrie, Gerasimos Filippatos, et alSeferović PM et al. Eur J Heart Fail. 8 March, 2018. Epub ahead of print.
Post-Hoc/Subgroup Analysis Of Pivotal Trials - Elderly
-
Giuseppe Patti, Ilaria Cavallari, Olivier Hanon, et alPatti G et al. Int J Cardiol. 2018;265:118-124.
-
Satoshi Yanagisawa, Yasuya Inden, Aya Fujii, et alYanagisawa S et al. JACC Clin Electrophysiol. 2018;4:592-600.
Other Studies
-
Deirdre A Lane, Juliane Meyerhoff, Ute Rohner, et alLane DA et al. Clin Cardiol. 2018;41:855-861. 12 June, 2018. Epub ahead of print.
Ablation strategies
-
Jason G Andrade, Nathaniel M. Hawkins, Christopher B. Fordyce, et alAndrade JG al. Can J Cardiol. 2018. Article in press.
-
Naga Venkata Pothineni, Srikanth VallurupalliUS Cardiology Review 2018;12(2):103–6.DOI: https://doi.org/10.15420/usc.2017:39:1
-
Raymond B Fohtung, Michael W RichUS Cardiology Review 2016;10(2):60–4DOI: https://doi.org/10.15420/usc.2016:1:1
-
Piotr PonikowskiEuropean Cardiology Review,2012 ; (3):150
-
Gerhard HindricksEuropean Cardiology Review,2012 ; (3):174 - 8DOI: http://dx.doi.org/10.15420/ecr.2012.8.3.174
